Karl Pfleger calls time on the aging debate, and

Complex I inhibitors promote tissue regeneration

Immortal Dragons aims to ‘redefine how capital

Oxford study shows timing and sequence of illnes

Wearable tech firm ‘respectfully disagrees’

Bernard Siegel says new state laws show the fede

Mouse study links telomerase activity to a trunc

Evidence-based medicine AI platform bags $210m t

Pretzel Therapeutics aims to restore cellular en

UK Biobank hits 100,000 scan milestone, as data

A novel technology in London claims to support c

Illimis Therapeutics harnesses key receptor syst

Ahead of the sixth TimePie Longevity Forum, Hebe

Ahead of the International Longevity Summit, Jos

Integrated Biosciences’ modular platform targe

ScienceMachine lands early stage funding for bio

Big Pharma granted option to acquire blood-brain

Norwegian partnership positions NAD+ precursor a

Lara Lewington’s new book Hacking Humanity exp

Companies collaborate to offer AI powered assess

Connectome aims to make neuroimaging an affordab

Alina M Hernandez explains why the longevity ind

Cynata CEO explains why standardized stem cell t

Startup harnesses data from consumer wearables t

Milestones plus escalating royalties position Ge

Company plans to move ‘swiftly’ into efficac

ProtoBind-Diff generates novel compounds from pr

Platform can help uncover how aging contributes

OBS Founder Marie Kruth reflects on a night of c

New study proposes metrics to refine perturbatio

Canadian healthtech integrates blood testing, we

Evvy co-founder explains how ignoring female bio

Pet longevity biotech boasts stem cell therapies

Atrogi’s oral candidate mimics exercise to pre

Khosla-backed company aims to double number of l

Buck Institute study reveals how sugar breakdown

Licensing agreement with Chinese biotech Mabwell

NFX General Partner Omri Drory discusses why lon

Immortal Dragons founder explains how a purpose-

Clinical stage ‘mitochondrial augmentation’

New analyses reveal widespread discrepancies in

Real-world data suggest GLP-1 drugs like Ozempic

Researchers propose protocol for standardizing l

New study maps aging markers in dogs and investi

Platform that predicts disease and phenotype dir

New Longitude Prize to award £7.

FastWave’s Sola IVL device completes first-in-

Company’s antibody profiling technology could

New review from global geroscience experts maps

Combining next generation sequencing with advanc